Menu Close

RxChange Co.

RxChange Co. is a pharmaceutical company that focuses on providing generic medications and innovative pharmaceutical solutions.

RxChange Co.
RxChange Co.

Here’s an overview of RxChange Co., including its mission, products, and role in the pharmaceutical industry:

Overview

Mission and Vision

  • Mission: RxChange Co. aims to enhance patient access to affordable, high-quality generic medications. The company is dedicated to improving healthcare by providing cost-effective alternatives to brand-name drugs.
  • Vision: To become a leading provider of generic pharmaceuticals, ensuring that patients worldwide have access to essential medications.

Key Areas of Focus

  1. Generic Medications
    • Product Range: Offers a wide range of generic drugs covering various therapeutic areas such as cardiovascular, central nervous system, anti-infectives, oncology, and more.
    • Affordability: Focuses on providing medications at lower costs compared to brand-name equivalents, helping to reduce healthcare expenses for patients and healthcare systems.
  2. Research and Development
    • Innovation: Invests in research and development to create new generic formulations and improve existing ones. The goal is to ensure bioequivalence to branded drugs and maintain high standards of quality and efficacy.
    • Regulatory Compliance: Ensures that all products meet stringent regulatory requirements set by authorities such as the FDA (Food and Drug Administration) and EMA (European Medicines Agency).
  3. Quality Assurance
    • Manufacturing Standards: Adheres to Good Manufacturing Practices (GMP) to ensure the highest quality of products. This includes rigorous testing and quality control measures throughout the manufacturing process.
    • Safety and Efficacy: Committed to ensuring that all products are safe, effective, and reliable for patients.

Strategic Initiatives

  1. Market Expansion
    • Global Reach: Aims to expand its presence in international markets, providing generic medications to patients across various regions, including North America, Europe, Asia, and Africa.
    • Partnerships and Collaborations: Engages in strategic partnerships and collaborations with other pharmaceutical companies and healthcare organizations to broaden its product portfolio and market reach.
  2. Cost-Effectiveness
    • Affordable Healthcare Solutions: Focuses on reducing the cost of medications through efficient manufacturing processes and economies of scale, passing on savings to consumers and healthcare providers.
    • Health System Support: Works with healthcare systems and providers to integrate generic medications into treatment protocols, helping to manage healthcare costs effectively.
  3. Patient Accessibility
    • Distribution Networks: Develops robust distribution networks to ensure timely and widespread availability of medications.
    • Patient Assistance Programs: Implements programs to assist patients in accessing medications, particularly those who are underinsured or uninsured.

Corporate Responsibility

  1. Ethical Practices
    • Transparency: Committed to transparency in its operations, including clear communication about product information and pricing.
    • Compliance: Ensures compliance with all regulatory and ethical standards in every market where it operates.
  2. Sustainability
    • Environmental Stewardship: Implements sustainable practices in manufacturing and distribution to minimize environmental impact.
    • Community Engagement: Participates in community health initiatives and supports local healthcare efforts to improve public health outcomes.
  3. Patient Safety
    • Pharmacovigilance: Maintains a robust pharmacovigilance system to monitor and manage any adverse effects of medications, ensuring patient safety remains a top priority.

Future Outlook

  • Innovation and Development: Continues to invest in R&D to develop new generic medications and improve existing ones, ensuring a steady pipeline of cost-effective drugs.
  • Global Expansion: Aims to further expand its global footprint, making high-quality generic medications accessible to more patients worldwide.
  • Healthcare Collaboration: Seeks to strengthen partnerships with healthcare providers, governments, and other stakeholders to enhance healthcare delivery and patient outcomes.

Summary

RxChange Co. is dedicated to providing high-quality, affordable generic medications to improve patient access to essential healthcare treatments. Through its focus on innovation, quality assurance, and ethical practices, RxChange Co. aims to play a significant role in the global pharmaceutical industry, addressing the growing demand for cost-effective healthcare solutions. The company’s strategic initiatives in market expansion, patient accessibility, and corporate responsibility underscore its commitment to enhancing public health and supporting sustainable healthcare systems worldwide.

RxChange Co. is located at 2545 N Ontario St, Burbank, CA 91504.

You can contact them by phone at (818) 545-1177.

For more information, you can visit their official website at www.rxchangeco.com (Dun & Bradstreet)​ .

RxChange Co. Product List

Products with assigned NDCs are displayed.  Select the NDC to see product information.  Select the Trade Name to see similar products.

NDC Trade Name Labeler Name Deleted Deleted Date
33358-0002 Acetaminophen And Codeine RxChange Co. YES No later than 2019-12-28
33358-0001 Acetaminophen and Codeine RxChange Co. YES No later than 2019-03-18
33358-0901 Avalin External Analgesic Patch RxChange Co. YES No later than 2019-12-28
33358-0040 AZITHROMYCIN RxChange Co. YES No later than 2019-12-28
33358-0364 Bupropion hydrochloride RxChange Co. YES No later than 2019-12-28
33358-0059 Butalbital, Acetaminophen, and Caffeine RxChange Co. YES No later than 2019-12-28
33358-0064 CARISOPRODOL RxChange Co. YES No later than 2019-10-01
33358-0902 Celecoxib RxChange Co. YES No later than 2019-12-28
33358-0097 Cyclobenzaprine Hydrochloride RxChange Co. YES No later than 2019-12-28
33358-0451 Diclofenac Sodium RxChange Co. YES No later than 2019-12-28
33358-0153 Gabapentin RxChange Co. YES No later than 2019-12-28
33358-0154 Gabapentin RxChange Co. YES No later than 2019-12-28
33358-0187 ibuprofen RxChange Co. YES No later than 2019-12-28
33358-0188 Ibuprofen RxChange Co. YES No later than 2020-04-01
33358-0211 Lisinopril RxChange Co. YES No later than 2019-12-28
33358-0212 lisinopril RxChange Co. YES No later than 2019-12-28
33358-0213 lisinopril RxChange Co. YES No later than 2019-12-28
33358-0221 Lorazepam RxChange Co. YES No later than 2019-12-28
33358-0903 Megestrol Acetate Rxchange Co YES No later than 2019-12-28
33358-0251 Nabumetone RxChange Co. YES No later than 2019-12-28
33358-0252 Nabumetone RxChange Co. YES No later than 2019-12-28
33358-0259 Naproxen Sodium RxChange Co. YES No later than 2019-12-28
33358-0273 Omeprazole RxChange Co. YES No later than 2019-12-28
33358-0498 Ondansetron RxChange Co. YES No later than 2019-12-28
33358-0512 Ondansetron RxChange Co. YES No later than 2019-12-28
33358-0274 Orphenadrine Citrate RxChange Co. YES No later than 2019-12-28
33358-0536 Pantoprazole Sodium RxChange Co. YES No later than 2019-12-28
33358-0435 Phentermine Hydrochloride RxChange Co. YES No later than 2019-12-28
33358-0316 Ranitidine RxChange Co. YES No later than 2019-12-28
33358-0431 simvastatin RxChange Co. YES No later than 2019-12-28
33358-0475 simvastatin RxChange Co. YES No later than 2019-12-28
33358-0332 Temazepam RxChange Co. YES No later than 2019-12-28
33358-0342 Tramadol Hydrochloride RxChange Co. YES No later than 2019-12-28
33358-0343 Tramadol Hydrochloride and Acetaminophen RxChange Co. YES No later than 2019-12-28
33358-0530 Venlafaxine Hydrochloride RxChange Co. YES No later than 2019-12-28
33358-0420 ZOLPIDEM TARTRATE RxChange Co. YES No later than 2019-12-28
33358-0439 ZOLPIDEM TARTRATE RxChange Co. YES No later than 2019-12-28

Leave a Reply

Please leave correct email if you want us to contact you

Your email address will not be published. Required fields are marked *